Covance, ISB Partner on Brain Tumor Biology Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Contract research organization Covance today announced a collaboration between its genomics laboratory in Seattle and the Institute for Systems Biology to further research into brain tumor biology.

Specifically, Covance's expertise in genomics assays and ISB's expertise in complex genomic networks will be leveraged to unravel the regulation of gene expression in glioblastoma multiforme.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

Sponsored by
HTG Molecular

This webinar will discuss potential clinical applications for miRNA signatures and a novel, extraction-free miRNA profiling technology for advancing biomarker discovery. 

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.